Ross Jennens

A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer

Zarique Z Akanda, Paul J Neeson, Thomas John, Stephen Barnett, Gerard G Hanna, Alistair Miller, Ross Jennens, Shankar Siva

Journal article  |  2021  |  TRANSLATIONAL LUNG CANCER RESEARCH

Immune checkpoint inhibitors (ICIs) have significantly improved overall survival (OS) in metastatic non-small cell lung cancer (m-..

Standard-Dose Osimertinib in EGFR-Mutated Non-Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease

Luke S McLean, Wasek Faisal, Sagun Parakh, Steven C Kao, Craig R Lewis, Melvin T Chin, Mark Voskoboynik, Malinda J Itchins, Ross R Jennens, Adam R Broad, Tessa A Morris, Benjamin J Solomon

Journal article  |  2021  |  JCO PRECISION ONCOLOGY

PURPOSE: Leptomeningeal disease (LMD) in epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma is associated with a p..

Response to letter commenting on: Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancer

Evangeline Samuel, Cherie Chiang, Ross Jennens, David Faulkner, Prudence A Francis

Journal article  |  2020  |  EUROPEAN JOURNAL OF CANCER

Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancer

E Samuel, C Chiang, R Jennens, D Faulkner, PA Francis

Journal article  |  2020  |  EUROPEAN JOURNAL OF CANCER

Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival

Shehara Mendis, Sophie Beck, Belinda Lee, Margaret Lee, Rachel Wong, Suzanne Kosmider, Jeremy Shapiro, Desmond Yip, Simone Steel, Louise Nott, Ross Jennens, Lara Lipton, Matthew Burge, Kathryn Field, Sumitra Ananda, Hui-Li Wong, Peter Gibbs

Journal article  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

BACKGROUND: Metastatic colorectal cancer (mCRC) patients with a right-sided primary (RC) have an inferior survival to mCRC arising..

Left- versus right-side metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival.

Shehara Ramyalini Mendis, Belinda Lee, Margaret Lee, Rachel Wong, Suzanne Kosmider, Jeremy David Shapiro, Desmond Yip, Simone Anne Steel, Louise M Nott, Ross Jennens, Lara Rachel Lipton, Matthew E Burge, Kathryn Maree Field, Sumitra Ananda, Sophie Beck, Hui-Li Wong, Peter Gibbs

Conference Proceedings  |  2019  |  JOURNAL OF CLINICAL ONCOLOGY

623 Background: Patients with metastatic colorectal cancer (mCRC) arising from a right sided colorectal cancer (RC) have an infer..

The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailable

L Chin-Lenn, RH De Boer, E Segelov, GM Marx, TM Hughes, NJ McCarthy, SC White, SS Foo, JJ Rutovitz, S Della-Fiorentina, R Jennens, YC Antill, D Tsoi, MF Cronk, JM Lombard, BE Kiely, JH Chirgwin, A Gorelik, GB Mann

Journal article  |  2018  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

OBJECTIVES: Industry-supported decision impact studies demonstrate that Oncotype Dx (ODX) changes treatment recommendations (TR) i..